<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1025-0255</journal-id>
<journal-title><![CDATA[Revista Archivo Médico de Camagüey]]></journal-title>
<abbrev-journal-title><![CDATA[Arch méd Camagüey]]></abbrev-journal-title>
<issn>1025-0255</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de Camagüey]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1025-02552022000100047</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[La retinopatía diabética en la consulta de Retina del Hospital Universitario Manuel Ascunce Domenech]]></article-title>
<article-title xml:lang="en"><![CDATA[The diabetic retinopathy in the Retinal consultation of the Hospital Universitario Manuel Ascunce Domenech]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chávez-Pardo]]></surname>
<given-names><![CDATA[Iris]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cuéllar-Torres]]></surname>
<given-names><![CDATA[Olga Lidia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz-Ríos]]></surname>
<given-names><![CDATA[Arllety]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Rodríguez]]></surname>
<given-names><![CDATA[Mayelin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cardoso-Guillén]]></surname>
<given-names><![CDATA[Elías]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas Hospital Universitario Manuel Ascunce Domenech Servicio de Retina]]></institution>
<addr-line><![CDATA[Camagüey ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Ciencias Médicas Departamento de Informática Médica ]]></institution>
<addr-line><![CDATA[Camagüey ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Ciencias Médicas Hospital Universitario Manuel Ascunce Domenech Servicio de Catarata]]></institution>
<addr-line><![CDATA[Camagüey ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<volume>26</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1025-02552022000100047&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1025-02552022000100047&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1025-02552022000100047&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  La retinopatía diabética es la complicación microvascular más común de la diabetes mellitus. Niveles elevados de glucosa en sangre inducen cambios estructurales, fisiológicos y hormonales que afectan a los capilares de la retina. La retinopatía inicia su desarrollo al menos siete años antes del diagnóstico de diabetes mellitus tipo 2.  Objetivo:  Describir el comportamiento dela retinopatía diabética en pacientes atendidos en la consulta de Retina del Hospital Universitario Manuel Ascunce Domenech de la provincia Camagüey.  Métodos: Se realizó un estudio descriptivo, longitudinal en pacientes con el diagnóstico de retinopatía diabética. La población la conformaron 330 pacientes que acudieron a la consulta, en el periodo de enero a noviembre 2019 y que cumplieron con los criterios de selección. Se diseñó un formulario de recolección de datos y se estudiaron variables independientes: edad, sexo, factores de riesgo, tiempo de evolución de la enfermedad y como variable dependiente la severidad de la retinopatía.  Resultados:  El comportamiento de los grupos de edades entre 41 y 60 años, fue más frecuente, seguido de pacientes entre 20 y 40 año que padecieron de retinopatía diabética proliferativas. El mal control glucémico fue el factor de riesgo más frecuente, seguido de la hipertensión arterial. Entre 17 y 21 años de enfermedad, se encontraron la mayor cantidad de pacientes, seguido de los pacientes de 22 a 27 años de enfermedad.  Conclusiones:  Predominó en el estudio la edad entre 41 y 60 años. Todos los pacientes presentaron más de un factor de riesgo. El mal control glucémico y la hipertensión arterial fueron los factores de riesgo más frecuente en el estudio. El tiempo de evolución de la enfermedad predominó entre 17 y 21 años. Existió relación entre edad del paciente, factores de riesgo y tiempo de evolución de la enfermedad con la severidad de la retinopatía diabética, donde predominó la retinopatía diabética proliferativa.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: Diabetic retinopathy isthemostcommonmicrovascularcomplication of diabetes mellitus. Elevatedlevels of glucose in theblood induce structural, physiological and hormonal changesthataffectthecapillaries of the retina. Retinopathy beginsitsdevelopment at leastsevenyearsbeforethe diagnosis of type 2 diabetes mellitus.  Objective: To describe thebehavior of diabetic retinopathy in patientstreated at the Retina clinic of the Manuel Ascunce Domenech University Hospital in Camagüey province.  Methods: Adescriptive, longitudinal study in patientswiththe diagnosis of diabetic retinopathy wascarriedout. 330 patientsthatattendedtheretinalconsultation in theperiodfromJanuarytoNovember, 2019 and thattheyfulfilledtheselectioncriteria, conformedthepopulation. A collectingfill-outform of data wasdesigned and independent variables: Age, sex, risk factors, time of evolution of disease and likedependent variable theseverity of retinopathy, werestudied.  Results: Thebehavior of theagegroupsbetween 41 and 60 years, was more frequent, followedbypatientsbetween 20 and 40 yearthattheysufferedfromproliferative diabetic retinopathy. Thebadglycemic control wasthemostfrequent risk factor, followedbyhighbloodpressure. Thegreatestquantity of patientshadbetween 17 and 21 years of disease, followedbythosepatientsbetween 22 and 27 years of disease.  Conclusions: Theagebetween 41 and 60 yearsprevailed in thestudy. Allpatientshad more thanone risk factor. Poor glycemic control and arterial hypertensionwerethemostfrequent risk factors in thestudy. Thedisease&#8217;sevolution time between 17 and 21 years of illnesspredominated. Therewas a relationshipbetweenthepatient'sage, risk factors and time of evolution of thediseasewiththeseverity of diabetic retinopathy, whereproliferative diabetic retinopathy predominated.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[DIABÉTICA]]></kwd>
<kwd lng="es"><![CDATA[CONTROL GLUCÉMICO]]></kwd>
<kwd lng="es"><![CDATA[FACTORES DE RIESGO CARDIOMETABÓLICO]]></kwd>
<kwd lng="es"><![CDATA[FACTORES DE TIEMPO]]></kwd>
<kwd lng="es"><![CDATA[PREVALENCIA]]></kwd>
<kwd lng="en"><![CDATA[RETINOPATHY]]></kwd>
<kwd lng="en"><![CDATA[GLYCEMIC CONTROL]]></kwd>
<kwd lng="en"><![CDATA[CARDIOMETABOLIC RISK FACTORS]]></kwd>
<kwd lng="en"><![CDATA[TIME FACTORS]]></kwd>
<kwd lng="en"><![CDATA[PREVALENCE]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furtado]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Lansingh]]></surname>
<given-names><![CDATA[VC]]></given-names>
</name>
<name>
<surname><![CDATA[Carter]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Milanese]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Peña]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Ghersi]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Causes of blindness and visual impairment In Latin America]]></article-title>
<source><![CDATA[Surv Ophtalmol]]></source>
<year>2012</year>
<volume>57</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>149-77</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Internacional Diabetes Federation</collab>
<source><![CDATA[Diabetes Atlas]]></source>
<year>2017</year>
<edition>8va</edition>
<publisher-loc><![CDATA[Bélgica ]]></publisher-loc>
<publisher-name><![CDATA[IDF]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Anuario Estadístico de Salud 2019]]></source>
<year>2020</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Dirección de Registros Médicos y Estadísticas de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ponto KA]]></surname>
<given-names><![CDATA[Koenig J]]></given-names>
</name>
<name>
<surname><![CDATA[Peto T]]></surname>
<given-names><![CDATA[Lamparter J]]></given-names>
</name>
<name>
<surname><![CDATA[RaumPh]]></surname>
<given-names><![CDATA[Wild PS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: resultsfromthe Gutenberg Health Study (GHS)]]></article-title>
<source><![CDATA[Diabetologia]]></source>
<year>2016</year>
<volume>59</volume>
<page-range>1913-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adrianzén]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Rioja]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Manrique]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frecuencia y severidad de retinopatía diabética en pacientes con diabetes mellitus tipo 2 en el Instituto Regional de Oftalmología]]></article-title>
<source><![CDATA[Rev perú med exp salud publica]]></source>
<year>2019</year>
<volume>36</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>Federación Internacional de Diabetes</collab>
<source><![CDATA[Plan Mundial contra la Diabetes 2011-2021]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Bélgica ]]></publisher-loc>
<publisher-name><![CDATA[FID]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pineda Sarabia]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Zarco Vite]]></surname>
<given-names><![CDATA[XJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz Morales]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retinopatía diabética, una complicación descuidada.]]></article-title>
<source><![CDATA[Aten Fam]]></source>
<year>2018</year>
<volume>2582</volume>
<page-range>83-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abuabuad]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Guzmán]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Urzúa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de retinopatía diabética y edema macular en población Diabética del CESFAM Cordillera Andina de los Andes]]></article-title>
<source><![CDATA[Rev Chil Salud Pública]]></source>
<year>2014</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>81-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title xml:lang=""><![CDATA[Standards of Medical Care in Diabetes-2016: summary of revisions]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2016</year>
<volume>39</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S4-5</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>American Academy of Ophthalmology</collab>
<source><![CDATA[Diabetic Retinopathy Preferred Practice Pattern®]]></source>
<year>2017</year>
<publisher-loc><![CDATA[San Francisco, CA ]]></publisher-loc>
<publisher-name><![CDATA[American Academy of Ophthalmology]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Verdaguer Terradella]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez Castro]]></surname>
<given-names><![CDATA[FG]]></given-names>
</name>
<name>
<surname><![CDATA[Barría von-Bischhoffshause]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Actualización de la Guía Clínica de Retinopatía Diabética para Latinoamérica]]></source>
<year>2016</year>
<publisher-loc><![CDATA[San Francisco, California ]]></publisher-loc>
<publisher-name><![CDATA[International Council of ophthalmology]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[KY]]></given-names>
</name>
<name>
<surname><![CDATA[Theodoratou]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rudan]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Journal global health]]></source>
<year>2018</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilkinson]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Ferris]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
<name>
<surname><![CDATA[Agardh]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Proposed International Clinical Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales]]></article-title>
<source><![CDATA[Ophthalmology]]></source>
<year>2003</year>
<volume>110</volume>
<numero>9</numero>
<issue>9</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murillo García]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Evolución del fondo de ojo con respecto a las cifras de hemoglobina glucada]]></source>
<year>2017</year>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Universidad de Extremadura]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Salas Osorio]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Calle]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Salcedo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mestra]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación de los factores de riesgo en la salud visual de los pacientes con retinopatía diabética]]></article-title>
<source><![CDATA[Ciencia y Salud Virtual]]></source>
<year>2019</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>27-35</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallejo Mesa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Alvira]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología de la retinopatía diabética y su relación con la diabetes]]></article-title>
<source><![CDATA[Rev Colombiana de Endocrinología, Diabetes y Metabolismo]]></source>
<year>2016</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>12-5</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hirakawa]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
<name>
<surname><![CDATA[Nakahima]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[ALC]]></given-names>
</name>
<name>
<surname><![CDATA[Ribeiro]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
<name>
<surname><![CDATA[Ticianeli]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conhecimento dos pacientes diabéticos usuários do Sistema Único de Saúde acerca da retinopatía diabética]]></article-title>
<source><![CDATA[Rev Bras Oftalmol]]></source>
<year>2019</year>
<volume>78</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>107-11</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[TY]]></given-names>
</name>
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kawasaki]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ruamviboonsuk]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Lansingh]]></surname>
<given-names><![CDATA[VC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings]]></article-title>
<source><![CDATA[Ophthalmology]]></source>
<year>2018</year>
<volume>125</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1608-22</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barría von-Bischhoffshausen]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez Castro]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Verdaguer Terradella]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Actualización de la Guía Clínica de Retinopatía Diabética para Latinoamérica]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Texas ]]></publisher-loc>
<publisher-name><![CDATA[Asociación Panamericana de Oftalmologia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Ferrer]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos López]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Molina Santana]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Chang Hernández]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Perera Miniet]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Galindo Reydmond]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estrategias en el tratamiento de la retinopatía diabética]]></article-title>
<source><![CDATA[Rev cuba oftalmol]]></source>
<year>2018</year>
<volume>31</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tobaru-Miyashiro]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Guzmán-Ahumada]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retinopatía diabética]]></article-title>
<source><![CDATA[Diagnóstico]]></source>
<year>2019</year>
<volume>58</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>85-90</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schreur]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[van Asten]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ng]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Weeda]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Groenewoud]]></surname>
<given-names><![CDATA[JMM]]></given-names>
</name>
<name>
<surname><![CDATA[Tack]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus]]></article-title>
<source><![CDATA[Acta Ophthalmol]]></source>
<year>2018</year>
<volume>96</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>459-64</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<collab>Programa Visión 2020/IAPB, Latinoamérica, Asociación Panamericana de Oftalmología (APAO), Christian BlindMission</collab>
<source><![CDATA[Guía práctica clínica de retinopatía diabética para Latinoamérica: dirigida a Oftalmólogos y profesionales de la Salud]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Querétaro ]]></publisher-loc>
<publisher-name><![CDATA[IAPB]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Loza Zenteno]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
</person-group>
<source><![CDATA[Caracterización de la retinopatía diabética en pacientes diabéticos en la Unidad Nacional de Oftalmología]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Guatemala ]]></publisher-loc>
<publisher-name><![CDATA[Universidad de San Carlos de Guatemala]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández Pérez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tirado Martínez]]></surname>
<given-names><![CDATA[OM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fotocoagulación panretinal y bevacizumab intravítreo en el tratamiento de la retinopatía diabética proliferativa activa]]></article-title>
<source><![CDATA[Rev cuba oftalmol]]></source>
<year>2014</year>
<volume>27</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sugimoto]]></surname>
<given-names><![CDATA[MAA]]></given-names>
</name>
<name>
<surname><![CDATA[Coelho Peixoto de Toledo]]></surname>
<given-names><![CDATA[VP]]></given-names>
</name>
<name>
<surname><![CDATA[Ribeiro Cunha]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Carregal]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
<name>
<surname><![CDATA[Jorge]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Leão]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of bevacizumab (Avastin®) repacked in single-use glass vials for intravitreal administration]]></article-title>
<source><![CDATA[Arq Bras Oftalmol]]></source>
<year>2017</year>
<volume>80</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mohamed]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Esraa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Eshak]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Oumaima]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Amr]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bevacizumab intravítreo versus triamcinolonaintravítrea para el edema macular diabético: revisión sistemática, metanálisis y metarregresión]]></article-title>
<source><![CDATA[PlosOne]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Xia]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antivascular endothelial growth factor agentspretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials]]></article-title>
<source><![CDATA[Br J Ophthalmol]]></source>
<year>2018</year>
<volume>102</volume>
<page-range>1077-85</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hennings]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gillies]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Campain]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fraser-Bell]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular o edema]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2018</year>
<volume>2018</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Virgili]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Parravano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Evans]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Gordon]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Lucenteforte]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.]]></article-title>
<source><![CDATA[Cochrane Database Systematic Reviews]]></source>
<year>2017</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
